Rh-endostatin with consolidative thoracic radiotherapy improves progression-free survival and exhibits a trend towards reduced severe pneumonitis in stage IV NSCLC after first-line immunochemotherapy
Fields of Study & Subjects
Lung Cancer Diagnosis and Treatment
Lung Cancer Treatments and Mutations
Lung Cancer Research Studies
Publication details
- Journal / source
- SSRN Electronic Journal
- Publication date
- 1 January 2026
- Language
- EN
- Document type
- Preprint